Clinical Trial Update: Pharmacokinetics of IAsp Following CSII in Patients With T1DM [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study update examining insulin aspart administered by continuous subcutaneous insulin infusion in patients with Type 1 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)

Snippet

Sponsor: University of Aarhus | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED